Ki16425

1 1

Selleck Chemicals

S1315-2MG

€144,00 EUR
€144,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

Ki16425 is an antagonist linked to GPCR Signaling and related pathway-oriented research. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to receptor-driven second-messenger signaling and desensitization dynamics in biochemical and cell-based models.

The pathway annotation connects Ki16425 to GPCR Signaling, supporting experiments that monitor receptor-driven second-messenger signaling and desensitization dynamics across biochemical, cellular, or phenotypic assay formats. This context is compatible with ligand-response, cAMP, calcium-flux, and receptor-pharmacology assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. When a fully resolved mechanism is unavailable, parallel readouts such as viability, reporter activity, morphology, localization, or biochemical conversion can still help position the compound experimentally.

Research Applications

  • Pathway perturbation studies connected to GPCR Signaling
  • Receptor-blockade and ligand-competition studies
  • Combination studies with orthogonal perturbagens
  • Mechanism-oriented follow-up using biochemical and cellular endpoints

Overall, Ki16425 is well suited to pathway-oriented studies that need a defined compound input for GPCR Signaling readouts in biochemical and cell-based models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Pathways:
GPCR Signaling
CAS No.:
355025-24-0
Molecular Weight:
474.96
Formula:
C₂₃H₂₃ClN₂O₅S
SMILES:
CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2Cl)C3=CC=C(C=C3)CSCCC(=O)O
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.